Hyperfine, Inc. (HYPR) stock analysis

P/E against its history

Not enough price and earnings history to compare.

P/E against the industry

Needs positive earnings and enough profitable companies in the industry.

EV/EBITDA against its history

Needs positive EBITDA and price history.

P/B below the industry

Hyperfine's price-to-book of 2.38 is below the Surgical, Medical, and Dental Instruments and Supplies median of 3.22.

Trading below fair value

The share price of $0.71 is below our fair value estimate of $0.77.

Margin of safety under 20%

The price is 7.8% below fair value, less than the 20% cushion we look for.

Revenue growing 10%+ a year

Revenue grew 25.8% a year over the last three fiscal years.

EPS growth over 3 years

Needs positive EPS three years ago and today.

Earnings acceleration

Needs positive net income now, a year ago and five years ago.

Growing faster than the industry

Revenue grew 80.0% over the last twelve months; the Surgical, Medical, and Dental Instruments and Supplies median is 11.0%.

Guidance raised

Hyperfine raised its full year 2025 revenue outlook on Nov 13, 2025.

Gross margin improving

Gross margin was 52.6% over the last twelve months, against 46.1% a year earlier.

Return on equity under 15%

Return on equity was -102% over the last twelve months and averaged -62.9% over five years; we look for 15% on both.

Return on capital under 10%

Return on invested capital was -403%, below the 10% that usually covers the cost of capital.

Return on equity below the industry

Hyperfine's return on equity of -102% is below the Surgical, Medical, and Dental Instruments and Supplies median of -31.3%.

Earnings over 5 years

Needs positive net income five years ago and in the latest year.

Net margin above its 5-year average

Net margin was -156% over the last twelve months, against a 5-year average of -1193%.

Net margin below the industry

Hyperfine's net margin of -156% is below the Surgical, Medical, and Dental Instruments and Supplies median of -14.1%.

High debt

Debt is 42.1% of shareholders' equity, above the 40% we consider low.

Debt trend

Needs a balance sheet from five years ago with positive equity.

Debt not well covered by cash flow

Operating cash flow over the last twelve months equals -206% of total debt; we look for at least 20%.

Interest coverage

Interest expense is not reported separately.

Short-term assets cover short-term debts

Current assets are 5.10 times current liabilities.

Elevated bankruptcy risk

The Altman Z-score is -7.43; above 3 is the safe zone and below 1.8 the distress zone.

No dividend

Hyperfine has not paid a dividend in the last twelve months.

Yield against Treasuries

No dividend.

Yield against the market

No dividend.

Dividend stability

No dividend.

Earnings cover

No dividend.

Cash-flow cover

No dividend.